It details the possible financial motives she had to manipulate the findings of her CT lung cancer screening results:
In today’s correction, the New England Journal acknowledges that the study’s lead authors, Claudia Henschke and David Yankelevitz of Cornell University’s Weill Medical College in New York City, received royalties from GE, a big maker of CT scanners, for pending patents on ways to manipulate and interpret CT scans and other medical images.
Related posts:
- Claudia Henschke disgraced
- Did Claudia Henschke take cigarette money?
- Claudia Henschke and "blood money"
- My take: Henschke, insolvency, MIs, specificity
- Lung cancer screening
- COURAGE trial: The NEJM strikes back
- Did privacy laws get in the way of the Plaxico Burress case?
KevinMD.com on Facebook
Comments on this entry are closed.